Replies to post #1 on Genentech Inc

[arconway]

Here is more news:

Genentech Inc. signed a deal with a nonprofit foundation in Burlingame to study the use of its colorectal cancer drug Avastin as a treatment for brain cancer.
The Food and Drug Administration approved Avastin in February 2004 for colorectal cancer treatment. The drug interferes with angiogenesis, or the growth of blood vessels, in tumors. Genentech has been exploring its use for other types of cancer, including kidney, breast and ovarian.

This baby is a profit machine.